Cargando…
Cell-Based Therapy for Silicosis
Silicosis is the most common pneumoconiosis globally, with higher prevalence and incidence in developing countries. To date, there is no effective treatment to halt or reverse the disease progression caused by silica-induced lung injury. Significant advances have to be made in order to reduce morbid...
Autores principales: | Lopes-Pacheco, Miquéias, Bandeira, Elga, Morales, Marcelo M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4811211/ https://www.ncbi.nlm.nih.gov/pubmed/27066079 http://dx.doi.org/10.1155/2016/5091838 |
Ejemplares similares
-
Therapeutic effects of bone marrow-derived mononuclear cells from healthy or silicotic donors on recipient silicosis mice
por: de Oliveira, Helena D’Anunciação, et al.
Publicado: (2017) -
Therapeutic effects of adipose-tissue-derived mesenchymal stromal cells and their extracellular vesicles in experimental silicosis
por: Bandeira, Elga, et al.
Publicado: (2018) -
Dasatinib Reduces Lung Inflammation and Fibrosis in Acute Experimental Silicosis
por: Cruz, Fernanda Ferreira, et al.
Publicado: (2016) -
Infusion of Bone Marrow Mononuclear Cells Reduces Lung Fibrosis but Not Inflammation in the Late Stages of Murine Silicosis
por: Lopes-Pacheco, Miquéias, et al.
Publicado: (2014) -
Pilot safety study of intrabronchial instillation of bone marrow-derived mononuclear cells in patients with silicosis
por: Morales, Marcelo M., et al.
Publicado: (2015)